TCGA-97-8547, TCGA-97-8547SENT_1,"SURGICAL PATHOLOGY REPORT","{SURGICAL,PATHOLOGY,REPORT}","{surgical,pathology,report}","{JJ,NN,NN}","{3,3,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_2,"COLLECTION DATESPECIIVIENS : 1 .","{COLLECTION,DATESPECIIVIENS,:,1,.}","{collection,datespeciivien,:,1,.}","{NN,NNS,:,CD,.}","{2,0,0,2,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_3,"RT .","{RT,.}","{rt,.}","{NN,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_4,"LOWER LOBE ( PRECISION ) 2 .","{LOWER,LOBE,(,PRECISION,),2,.}","{lower,lobe,(,precision,),2,.}","{RBR,JJ,JJ,NN,NN,CD,.}","{2,4,4,0,4,5,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_5,"RT .","{RT,.}","{rt,.}","{NN,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_6,"LEVEL 11 LYMPH NODE 3 .","{LEVEL,11,LYMPH,NODE,3,.}","{level,11,lymph,node,3,.}","{NN,CD,NN,NN,CD,.}","{4,4,4,0,4,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_7,"LUNG , RIGHT LOWER LOBE 4 .","{LUNG,,,RIGHT,LOWER,LOBE,4,.}","{lung,,,RIGHT,LOWER,LOBE,4,.}","{NN,,,NNP,NNP,NNP,CD,.}","{0,0,5,5,1,5,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_8,"RIGHT LEVEL 11 LYMPH NODE NEAR RIGHT UPPER LOBE 5 .","{RIGHT,LEVEL,11,LYMPH,NODE,NEAR,RIGHT,UPPER,LOBE,5,.}","{right,level,11,LYMPH,NODE,near,RIGHT,UPPER,LOBE,5,.}","{NN,NN,CD,NNP,NNP,IN,NNP,NNP,NNP,CD,.}","{2,0,5,5,2,0,9,9,5,9,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_9,"RIGHT LEVEL 7 LYMPH NODE 6 .","{RIGHT,LEVEL,7,LYMPH,NODE,6,.}","{right,level,7,lymph,node,6,.}","{NN,NN,CD,NN,NN,CD,.}","{2,0,5,5,2,5,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_10,"RT .","{RT,.}","{rt,.}","{NN,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_11,"LEVEL 4 LYMPH NODE 7 .","{LEVEL,4,LYMPH,NODE,7,.}","{level,4,LYMPH,node,7,.}","{NN,CD,NNP,NN,CD,.}","{3,3,0,3,4,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_12,"RIB SEE ADDENDUM","{RIB,SEE,ADDENDUM}","{rib,see,addendum}","{NN,VBP,NN}","{2,0,2}","{}"
TCGA-97-8547, TCGA-97-8547SENT_13,"Reason For Addendum # 1 : Molecular Studies Reason For Addendum # 2 : Molecular Studies DIAGNOSIS : 1 .","{Reason,For,Addendum,#,1,:,Molecular,Studies,Reason,For,Addendum,#,2,:,Molecular,Studies,DIAGNOSIS,:,1,.}","{reason,for,Addendum,#,1,:,molecular,study,reason,for,Addendum,#,2,:,molecular,study,diagnosis,:,1,.}","{NN,IN,NNP,#,CD,:,JJ,NNS,NN,IN,NNP,#,CD,:,JJ,NNS,NNS,:,CD,.}","{0,1,2,5,3,0,9,9,1,9,10,13,11,0,16,17,1,0,17,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_14,"LUNG , RIGHT , LOWER LOBE : BIOPSY - SENT TO PRECISION THERAPEUTICS ( GROSS ONLY ) .","{LUNG,,,RIGHT,,,LOWER,LOBE,:,BIOPSY,-,SENT,TO,PRECISION,THERAPEUTICS,(,GROSS,ONLY,),.}","{lung,,,RIGHT,,,LOWER,LOBE,:,biopsy,-,sent,to,PRECISION,THERAPEUTICS,(,GROSS,ONLY,),.}","{NN,,,NNP,,,NNP,NNP,:,NN,:,JJ,TO,NNP,NNP,CD,NNP,NNP,NN,.}","{0,0,1,0,6,1,0,1,0,8,10,13,11,17,17,17,10,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_15,"2 .","{2,.}","{2,.}","{LS,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_16,"LYMPH NODE , RIGHT LEVEL 11 : BIOPSY - METASTATIC CARCINOMA IN FRAGMENTS OF ANTHRACOTIC LYMPH NODE AND","{LYMPH,NODE,,,RIGHT,LEVEL,11,:,BIOPSY,-,METASTATIC,CARCINOMA,IN,FRAGMENTS,OF,ANTHRACOTIC,LYMPH,NODE,AND}","{lymph,node,,,right,level,11,:,biopsy,-,metastatic,carcinoma,in,fragment,of,ANTHRACOTIC,LYMPH,NODE,and}","{NN,NN,,,NN,NN,CD,:,NN,:,NN,NN,IN,NNS,IN,NNP,NNP,NNP,CC}","{2,0,0,5,2,2,0,6,0,11,18,0,11,0,17,17,13,8}","{}"
TCGA-97-8547, TCGA-97-8547SENT_17,"SOFT TISSUE .","{SOFT,TISSUE,.}","{soft,tissue,.}","{JJ,NN,.}","{2,0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_18,"4 .","{4,.}","{4,.}","{LS,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_19,"LYMPH NODE , LEVEL 11 , RIGHT : BIOPSY - METASTATIC CARCINOMA IN LYMPH NODE .","{LYMPH,NODE,,,LEVEL,11,,,RIGHT,:,BIOPSY,-,METASTATIC,CARCINOMA,IN,LYMPH,NODE,.}","{lymph,node,,,level,11,,,RIGHT,:,biopsy,-,metastatic,carcinoma,in,LYMPH,NODE,.}","{NN,NN,,,NN,CD,,,NNP,:,NN,:,NN,NN,IN,NNP,NNP,.}","{2,0,0,2,4,0,2,0,2,0,12,2,0,15,12,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_20,"5 .","{5,.}","{5,.}","{CD,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_21,"LYMPH NODE , LEVEL 7 , RIGHT : BIOPSY - METASTATIC CARCINOMA IN FRAGMENTS OF LYMPH NODE .","{LYMPH,NODE,,,LEVEL,7,,,RIGHT,:,BIOPSY,-,METASTATIC,CARCINOMA,IN,FRAGMENTS,OF,LYMPH,NODE,.}","{lymph,node,,,level,7,,,RIGHT,:,biopsy,-,metastatic,carcinoma,in,fragment,of,LYMPH,NODE,.}","{NN,NN,,,NN,CD,,,NNP,:,NN,:,NN,NN,IN,NNS,IN,NNP,NNP,.}","{2,0,0,2,4,0,2,0,2,0,12,2,0,12,0,17,14,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_22,"6 .","{6,.}","{6,.}","{CD,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_23,"LYMPH NODE , LEVEL 4 , RIGHT : BIOPSY - FRAGMENTS OF LYMPH NODE , NEGATIVE FOR CARCINOMA .","{LYMPH,NODE,,,LEVEL,4,,,RIGHT,:,BIOPSY,-,FRAGMENTS,OF,LYMPH,NODE,,,NEGATIVE,FOR,CARCINOMA,.}","{lymph,node,,,level,4,,,RIGHT,:,biopsy,-,fragment,of,LYMPH,NODE,,,NEGATIVE,for,CARCINOMA,.}","{NN,NN,,,NN,CD,,,NNP,:,NN,:,NNS,IN,NNP,NNP,,,NNP,IN,NNP,.}","{2,0,0,2,4,0,2,0,2,0,2,0,14,11,0,14,0,16,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_24,"7 .","{7,.}","{7,.}","{CD,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_25,"RIB : EXCISION - SEGMENT OF RIB WITH NO DIAGNOSTIC ABNORMALITY .","{RIB,:,EXCISION,-,SEGMENT,OF,RIB,WITH,NO,DIAGNOSTIC,ABNORMALITY,.}","{rib,:,excision,-,segment,of,rib,with,no,diagnostic,abnormality,.}","{NN,:,NN,:,NN,IN,NN,IN,NN,NN,NN,.}","{0,0,1,0,3,3,6,3,11,11,8,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_26,"SUMMARY Specimens : 2 : RT .","{SUMMARY,Specimens,:,2,:,RT,.}","{summary,specimen,:,2,:,rt,.}","{NN,NNS,:,CD,:,NN,.}","{2,0,0,2,0,4,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_27,"LEVEL 11 LYMPH NODE 3 : LUNG , RIGHT LOWER LOBE 4 : RIGHT LEVEL 11 LYMPH NODE NEAR RIGHT UPPER LOBE 5 : RIGHT LEVEL 7 LYMPH NODE 6 : RT .","{LEVEL,11,LYMPH,NODE,3,:,LUNG,,,RIGHT,LOWER,LOBE,4,:,RIGHT,LEVEL,11,LYMPH,NODE,NEAR,RIGHT,UPPER,LOBE,5,:,RIGHT,LEVEL,7,LYMPH,NODE,6,:,RT,.}","{level,11,lymph,node,3,:,lung,,,RIGHT,LOWER,LOBE,4,:,right,level,11,LYMPH,NODE,near,RIGHT,UPPER,LOBE,5,:,right,level,7,lymph,node,6,:,rt,.}","{NN,CD,NN,NN,CD,:,NN,,,NNP,NNP,NNP,CD,:,NN,NN,CD,NNP,NNP,IN,NNP,NNP,NNP,CD,:,NN,NN,CD,NN,NN,CD,:,NN,.}","{4,4,4,0,4,0,4,0,11,11,7,11,0,15,4,18,18,15,0,22,22,18,22,0,26,4,29,29,26,26,0,4,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_28,"LEVEL 4 LYMPH NODE","{LEVEL,4,LYMPH,NODE}","{level,4,LYMPH,node}","{NN,CD,NNP,NN}","{0,4,4,1}","{}"
TCGA-97-8547, TCGA-97-8547SENT_29,"LUNG : Resection SPECIMEN Procedure : Lobectomy Specimen Integrity : Intact Specimen Laterality : Right Tumor Site : Lower lobe Tumor Focality : Unifocal TUMOR Histologic Type : Adenocarcinoma , mixed subtype EXTENT Tumor Size : Greatest dimension ( cm ) 4cm Additional Dimension ( cm ) : 3.5 cm X 2.5 cm Visceral Pleura Invasion : Present MARGINS Bronchial Margin Bronchial Margin Involvement by Invasive Carcinoma : Uninvolved by invasive carcinoma Bronchial Margin Involvement by Squamous Cell Carcinoma in situ ( CIS ) : Squamous cell carcinoma in situ ( CIS ) not identified at bronchial margin Vascular Margin : Uninvolved by invasive carcinoma ACCESSORY FINDINGS Treatment Effect : Not applicable Lymph-Vascular Invasion : Present LYMPH NODES Extranodal Extension : Present STAGE ( pTNM ) TNM Descriptors : Not applicable Primary Tumor ( pT ) : pT2a : Tumor greater than 3 cm , but 5 cm or less in greatest dimension surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus ( i.e. , not in the main bronchus ) ; or Tumor 5 cm or less in greatest dimension with any of the following features of extent : involves main bronchus , 2 cm or more distal to the carina ; invades the visceral pleura ; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not inolve the entire lung Regional Lymph Nodes ( pN ) pN2 : Metastasis in ipsilateral mediastinal and / or subcarinal lymph node ( s ) Comment ( s ) : The tumor is positive for TTF1 and negative for PAX-8 , compatible with a primary pulmonary neoplasm .","{LUNG,:,Resection,SPECIMEN,Procedure,:,Lobectomy,Specimen,Integrity,:,Intact,Specimen,Laterality,:,Right,Tumor,Site,:,Lower,lobe,Tumor,Focality,:,Unifocal,TUMOR,Histologic,Type,:,Adenocarcinoma,,,mixed,subtype,EXTENT,Tumor,Size,:,Greatest,dimension,(,cm,),4cm,Additional,Dimension,(,cm,),:,3.5,cm,X,2.5,cm,Visceral,Pleura,Invasion,:,Present,MARGINS,Bronchial,Margin,Bronchial,Margin,Involvement,by,Invasive,Carcinoma,:,Uninvolved,by,invasive,carcinoma,Bronchial,Margin,Involvement,by,Squamous,Cell,Carcinoma,in,situ,(,CIS,),:,Squamous,cell,carcinoma,in,situ,(,CIS,),not,identified,at,bronchial,margin,Vascular,Margin,:,Uninvolved,by,invasive,carcinoma,ACCESSORY,FINDINGS,Treatment,Effect,:,Not,applicable,Lymph-Vascular,Invasion,:,Present,LYMPH,NODES,Extranodal,Extension,:,Present,STAGE,(,pTNM,),TNM,Descriptors,:,Not,applicable,Primary,Tumor,(,pT,),:,pT2a,:,Tumor,greater,than,3,cm,,,but,5,cm,or,less,in,greatest,dimension,surrounded,by,lung,or,visceral,pleura,without,bronchoscopic,evidence,of,invasion,more,proximal,than,the,lobar,bronchus,(,i.e.,,,not,in,the,main,bronchus,),;,or,Tumor,5,cm,or,less,in,greatest,dimension,with,any,of,the,following,features,of,extent,:,involves,main,bronchus,,,2,cm,or,more,distal,to,the,carina,;,invades,the,visceral,pleura,;,associated,with,atelectasis,or,obstructive,pneumonitis,that,extends,to,the,hilar,region,but,does,not,inolve,the,entire,lung,Regional,Lymph,Nodes,(,pN,),pN2,:,Metastasis,in,ipsilateral,mediastinal,and,/,or,subcarinal,lymph,node,(,s,),Comment,(,s,),:,The,tumor,is,positive,for,TTF1,and,negative,for,PAX-8,,,compatible,with,a,primary,pulmonary,neoplasm,.}","{lung,:,Resection,SPECIMEN,Procedure,:,Lobectomy,Specimen,Integrity,:,Intact,Specimen,Laterality,:,Right,tumor,site,:,lower,lobe,tumor,focality,:,unifocal,tumor,histologic,type,:,adenocarcinoma,,,mixed,subtype,EXTENT,tumor,size,:,greatest,dimension,(,cm,),4cm,additional,dimension,(,cm,),:,3.5,cm,x,2.5,cm,visceral,Pleura,Invasion,:,present,margin,bronchial,margin,bronchial,margin,involvement,by,Invasive,Carcinoma,:,uninvolved,by,invasive,carcinoma,bronchial,margin,involvement,by,Squamous,Cell,Carcinoma,in,situ,(,ci,),:,squamous,cell,carcinoma,in,situ,(,ci,),not,identify,at,bronchial,margin,vascular,margin,:,uninvolve,by,invasive,carcinoma,accessory,finding,treatment,effect,:,not,applicable,lymph-vascular,Invasion,:,present,LYMPH,NODES,Extranodal,Extension,:,present,stage,(,ptnm,),TNM,Descriptors,:,not,applicable,primary,tumor,(,pt,),:,pt2a,:,tumor,greater,than,3,cm,,,but,5,cm,or,less,in,greatest,dimension,surround,by,lung,or,visceral,pleuron,without,bronchoscopic,evidence,of,invasion,more,proximal,than,the,lobar,bronchus,(,i.e.,,,not,in,the,main,bronchus,),;,or,tumor,5,cm,or,less,in,greatest,dimension,with,any,of,the,follow,feature,of,extent,:,involve,main,bronchus,,,2,cm,or,more,distal,to,the,carina,;,invade,the,visceral,pleuron,;,associate,with,atelectasis,or,obstructive,pneumonitis,that,extend,to,the,hilar,region,but,do,not,inolve,the,entire,lung,Regional,Lymph,Nodes,(,pn,),pn2,:,Metastasis,in,ipsilateral,mediastinal,and,/,or,subcarinal,lymph,node,(,s,),comment,(,s,),:,the,tumor,be,positive,for,ttf1,and,negative,for,pax-8,,,compatible,with,a,primary,pulmonary,neoplasm,.}","{NN,:,NNP,NNP,NNP,:,NNP,NNP,NNP,:,NNP,NNP,NNP,:,NNP,NN,NN,:,JJR,NN,NN,NN,:,JJ,NN,JJ,NN,:,NN,,,JJ,NN,NNP,NN,NN,:,JJS,NN,CD,NN,NN,CD,JJ,NN,CD,NN,NN,:,CD,NN,NN,CD,NN,JJ,NNP,NNP,:,JJ,NNS,JJ,NN,JJ,NN,NN,IN,NNP,NNP,:,JJ,IN,JJ,NN,JJ,NN,NN,IN,NNP,NNP,NNP,FW,FW,FW,NN,CD,:,JJ,NN,NN,FW,FW,FW,NN,CD,RB,VBN,IN,JJ,NN,JJ,NN,:,VBN,IN,JJ,NN,NN,NNS,NN,NN,:,RB,JJ,JJ,NNP,:,JJ,NNP,NNP,NNP,NNP,:,JJ,NN,CD,NN,CD,NNP,NNPS,:,RB,JJ,JJ,NN,CD,NN,CD,:,NN,:,NN,JJR,IN,CD,NN,,,CC,CD,NN,CC,JJR,IN,JJS,NN,VBN,IN,NN,CC,JJ,NN,IN,JJ,NN,IN,NN,RBR,JJ,IN,DT,JJ,NN,CD,FW,,,RB,IN,DT,JJ,NN,NN,:,CC,NN,CD,NN,CC,JJR,IN,JJS,NN,IN,DT,IN,DT,VBG,NNS,IN,NN,:,VBZ,JJ,NNS,,,CD,NN,CC,JJR,JJ,TO,DT,NN,:,VBZ,DT,JJ,NN,:,VBN,IN,NN,CC,JJ,NN,WDT,VBZ,TO,DT,JJ,NN,CC,VBZ,RB,VB,DT,JJ,NN,NNP,NNP,NNP,CD,NN,CD,NN,:,NNP,IN,JJ,JJ,CC,:,CC,JJ,NN,NN,NN,VBZ,CD,NN,NN,VBZ,CD,:,DT,NN,VBZ,JJ,IN,NN,CC,JJ,IN,NN,,,JJ,IN,DT,JJ,JJ,NN,.}","{278,0,278,278,278,0,278,278,278,0,278,278,278,0,278,278,278,0,278,278,278,278,0,278,278,278,278,0,278,0,278,278,278,278,278,0,278,278,278,278,278,278,278,278,278,278,278,0,278,278,278,278,278,278,278,278,0,278,278,278,278,278,278,278,278,278,278,0,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,0,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,0,278,278,278,278,278,278,278,278,0,278,278,278,278,0,278,278,278,278,278,0,278,278,278,278,278,278,278,0,278,278,278,278,278,278,278,0,278,0,278,278,278,278,278,0,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,0,278,278,278,278,278,278,0,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,0,278,278,278,0,278,278,278,278,278,278,278,278,0,278,278,278,278,0,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,0,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,278,0,278,278,278,278,278,278,278,278,278,278,0,278,278,278,278,278,0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_30,"Lymphovascular invasion is seen on an ERG immunostain .","{Lymphovascular,invasion,is,seen,on,an,ERG,immunostain,.}","{lymphovascular,invasion,be,see,on,a,erg,immunostain,.}","{JJ,NN,VBZ,VBN,IN,DT,NN,NN,.}","{2,4,4,0,0,8,8,4,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_31,"Foci of visceral pleural invasion are demonstrated on an elastic stain .","{Foci,of,visceral,pleural,invasion,are,demonstrated,on,an,elastic,stain,.}","{focus,of,visceral,pleural,invasion,be,demonstrate,on,a,elastic,stain,.}","{NNS,IN,JJ,JJ,NN,VBP,VBN,IN,DT,JJ,VBP,.}","{7,0,5,5,1,7,0,0,10,7,10,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_32,"Tumor is present in soft tissue adjacent to vascular margin .","{Tumor,is,present,in,soft,tissue,adjacent,to,vascular,margin,.}","{tumor,be,present,in,soft,tissue,adjacent,to,vascular,margin,.}","{NN,VBZ,JJ,IN,JJ,NN,JJ,TO,JJ,NN,.}","{3,3,0,0,6,3,3,0,10,3,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_33,"Rounded foci of tissue necrosis in the superior portion of the lobe are negative for acid fast and fungal organisms on special stains .","{Rounded,foci,of,tissue,necrosis,in,the,superior,portion,of,the,lobe,are,negative,for,acid,fast,and,fungal,organisms,on,special,stains,.}","{round,focus,of,tissue,necrosis,in,the,superior,portion,of,the,lobe,be,negative,for,acid,fast,and,fungal,organism,on,special,stain,.}","{VBN,NNS,IN,NN,NN,IN,DT,JJ,NN,IN,DT,NN,VBP,JJ,IN,NN,JJ,CC,JJ,NNS,IN,JJ,NNS,.}","{0,1,0,5,2,0,9,9,1,0,12,9,14,1,0,14,20,0,17,1,0,23,20,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_34,"Case reviewed in department consensus conference .","{Case,reviewed,in,department,consensus,conference,.}","{Case,review,in,department,consensus,conference,.}","{NNP,VBN,IN,NN,NN,NN,.}","{2,0,0,6,6,2,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_35,"Pathologist","{Pathologist}","{pathologist}","{NN}","{0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_36,"CLINICAL HISTORY AND PRE ? OPERATIVE DIAGNOSIS : Lung cancer","{CLINICAL,HISTORY,AND,PRE,?,OPERATIVE,DIAGNOSIS,:,Lung,cancer}","{clinical,history,and,pre,?,OPERATIVE,DIAGNOSIS,:,lung,cancer}","{JJ,NN,CC,NN,CD,NNP,NNP,:,NN,NN}","{2,0,0,2,4,7,2,0,10,7}","{}"
TCGA-97-8547, TCGA-97-8547SENT_37,"MACROSCOPIC DESCRIPTION : The specimen is received in seven parts , each labeled with the patient 's name .","{MACROSCOPIC,DESCRIPTION,:,The,specimen,is,received,in,seven,parts,,,each,labeled,with,the,patient,'s,name,.}","{macroscopic,description,:,the,specimen,be,receive,in,seven,part,,,each,label,with,the,patient,'s,name,.}","{JJ,NN,:,DT,NN,VBZ,VBN,IN,CD,NNS,,,DT,VBN,IN,DT,NN,POS,NN,.}","{2,0,0,5,7,7,2,0,10,7,0,7,12,0,16,18,0,13,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_38,"1 .","{1,.}","{1,.}","{LS,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_39,"Part one is received fresh , labeled ? right lower lobe ? .","{Part,one,is,received,fresh,,,labeled,?,right,lower,lobe,?,.}","{Part,one,be,receive,fresh,,,label,?,right,lower,lobe,?,.}","{NNP,CD,VBZ,VBN,JJ,,,VBN,RB,RB,JJR,NN,NN,.}","{4,1,4,0,4,0,4,7,8,12,12,8,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_40,"It consists of two irregular portions of grey and tan ? yellow rubbery to firm tissue measurin 1 X 0.8 X 0.5 cm and 1.1 X 0.9 X 0.6 cm .","{It,consists,of,two,irregular,portions,of,grey,and,tan,?,yellow,rubbery,to,firm,tissue,measurin,1,X,0.8,X,0.5,cm,and,1.1,X,0.9,X,0.6,cm,.}","{it,consist,of,two,irregular,portion,of,grey,and,tan,?,yellow,rubbery,to,firm,tissue,measurin,1,x,0.8,x,0.5,cm,and,1.1,x,0.9,x,0.6,cm,.}","{PRP,VBZ,IN,CD,JJ,NNS,IN,NN,CC,NN,CD,JJ,NN,TO,NN,NN,NN,CD,NN,CD,NN,CD,NN,CC,CD,NN,CD,NN,CD,NN,.}","{2,0,0,6,6,2,0,6,0,6,13,13,23,0,17,17,13,19,23,23,23,21,30,0,28,28,26,30,30,6,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_41,"Entirely submitted tog ?","{Entirely,submitted,tog,?}","{entirely,submit,tog,?}","{RB,VBN,NN,NN}","{2,0,4,2}","{}"
TCGA-97-8547, TCGA-97-8547SENT_42,"2 .","{2,.}","{2,.}","{LS,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_43,"Part two is received in saline , labeled ? right level 11 lymph node ? .","{Part,two,is,received,in,saline,,,labeled,?,right,level,11,lymph,node,?,.}","{Part,two,be,receive,in,saline,,,label,?,right,level,11,lymph,node,?,.}","{NNP,CD,VBZ,VBN,IN,NN,,,VBN,RB,JJ,NN,CD,NN,NN,NN,.}","{4,1,4,0,0,4,0,6,10,11,8,15,15,15,11,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_44,"It consists of a 1.8 X 1.5 X 0.8 cm aggregate of black soft rubbery anthracotic lymphoid tissue .","{It,consists,of,a,1.8,X,1.5,X,0.8,cm,aggregate,of,black,soft,rubbery,anthracotic,lymphoid,tissue,.}","{it,consist,of,a,1.8,x,1.5,x,0.8,cm,aggregate,of,black,soft,rubbery,anthracotic,lymphoid,tissue,.}","{PRP,VBZ,IN,DT,CD,NN,CD,NN,CD,NN,NN,IN,JJ,JJ,JJ,JJ,JJ,NN,.}","{2,0,0,6,6,2,6,11,11,11,2,0,18,18,18,18,18,11,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_45,"Entirely submitted in one cassette .","{Entirely,submitted,in,one,cassette,.}","{entirely,submit,in,one,cassette,.}","{RB,VBN,IN,CD,NN,.}","{2,0,0,5,2,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_46,"3 .","{3,.}","{3,.}","{LS,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_47,"Part three is received fresh , labeled ? right lower lobe ? .","{Part,three,is,received,fresh,,,labeled,?,right,lower,lobe,?,.}","{Part,three,be,receive,fresh,,,label,?,right,lower,lobe,?,.}","{NNP,CD,VBZ,VBN,JJ,,,VBN,RB,RB,JJR,NN,NN,.}","{4,1,4,0,4,0,4,7,8,12,12,8,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_48,"It consists of a 174 gram , 14.5 X 10 X 3 cm right lower lobe of the lung .","{It,consists,of,a,174,gram,,,14.5,X,10,X,3,cm,right,lower,lobe,of,the,lung,.}","{it,consist,of,a,174,gram,,,14.5,x,10,x,3,cm,right,lower,lobe,of,the,lung,.}","{PRP,VBZ,IN,DT,CD,NN,,,CD,NN,CD,NN,CD,NN,RB,JJR,NN,IN,DT,NN,.}","{2,0,0,6,6,2,0,9,6,11,9,13,14,9,16,9,0,19,16,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_49,"At the hilum , a 2.5 cm diameter , 0.3 cm long portion of bronchus and large vessels are noted .","{At,the,hilum,,,a,2.5,cm,diameter,,,0.3,cm,long,portion,of,bronchus,and,large,vessels,are,noted,.}","{at,the,hilum,,,a,2.5,cm,diameter,,,0.3,cm,long,portion,of,bronchus,and,large,vessel,be,note,.}","{IN,DT,NN,,,DT,CD,NN,NN,,,CD,NN,JJ,NN,IN,NNS,CC,JJ,NNS,VBP,VBN,.}","{0,3,20,0,8,8,8,20,0,11,8,13,11,0,13,0,18,13,20,0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_50,"The lung is previously incised through its visceral pleural surface revealing a 4 X 3.5 X 2.5 cm poorly ? circumscribed , firm , tan tumor with central tan ? white necrosis deep to the overlying puckered pleura .","{The,lung,is,previously,incised,through,its,visceral,pleural,surface,revealing,a,4,X,3.5,X,2.5,cm,poorly,?,circumscribed,,,firm,,,tan,tumor,with,central,tan,?,white,necrosis,deep,to,the,overlying,puckered,pleura,.}","{the,lung,be,previously,incise,through,its,visceral,pleural,surface,reveal,a,4,x,3.5,x,2.5,cm,poorly,?,circumscribe,,,firm,,,tan,tumor,with,central,tan,?,white,necrosis,deep,to,the,overlying,puckered,pleuron,.}","{DT,NN,VBZ,RB,VBN,IN,PRP$,JJ,JJ,NN,VBG,DT,CD,NN,CD,NN,CD,NN,RB,RB,VBN,,,NN,,,NN,NN,IN,JJ,NN,NN,JJ,NN,JJ,TO,DT,JJ,JJ,NN,.}","{2,5,5,5,0,0,10,10,10,5,10,18,18,18,18,18,18,11,11,5,5,0,33,0,26,23,0,30,30,26,32,26,5,0,38,38,38,33,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_51,"The overlying pleura is inked black and the specimen is serially sectioned along the long aXis of the lobe .","{The,overlying,pleura,is,inked,black,and,the,specimen,is,serially,sectioned,along,the,long,aXis,of,the,lobe,.}","{the,overlying,pleuron,be,ink,black,and,the,specimen,be,serially,section,along,the,long,axis,of,the,lobe,.}","{DT,JJ,NN,VBZ,VBN,JJ,CC,DT,NN,VBZ,RB,VBN,IN,DT,JJ,NN,IN,DT,NN,.}","{3,3,5,5,0,5,0,9,12,12,12,5,0,16,16,12,0,19,16,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_52,"The tumor abuts the pleural surface and is approximately 0.2 cm from the vascular margin and 0.6 cm from the bronchial margin .","{The,tumor,abuts,the,pleural,surface,and,is,approximately,0.2,cm,from,the,vascular,margin,and,0.6,cm,from,the,bronchial,margin,.}","{the,tumor,abut,the,pleural,surface,and,be,approximately,0.2,cm,from,the,vascular,margin,and,0.6,cm,from,the,bronchial,margin,.}","{DT,NN,VBZ,DT,JJ,NN,CC,VBZ,RB,CD,NN,IN,DT,JJ,NN,CC,CD,NN,IN,DT,JJ,NN,.}","{2,8,0,6,6,3,0,3,8,11,9,0,15,15,9,0,18,9,0,22,22,8,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_53,"There is also an ill ? defined , patchy tan ? yellow area that extends from the tumor to the superior portion of the lobe and terminates in two firm tan ? yellow nodules measuring 1.0 cm and 0.8 cm in greatest dimension .","{There,is,also,an,ill,?,defined,,,patchy,tan,?,yellow,area,that,extends,from,the,tumor,to,the,superior,portion,of,the,lobe,and,terminates,in,two,firm,tan,?,yellow,nodules,measuring,1.0,cm,and,0.8,cm,in,greatest,dimension,.}","{there,be,also,a,ill,?,define,,,patchy,tan,?,yellow,area,that,extend,from,the,tumor,to,the,superior,portion,of,the,lobe,and,terminate,in,two,firm,tan,?,yellow,nodule,measure,1.0,cm,and,0.8,cm,in,greatest,dimension,.}","{EX,VBZ,RB,DT,JJ,NN,VBN,,,JJ,NN,NN,JJ,NN,WDT,VBZ,IN,DT,NN,TO,DT,JJ,NN,IN,DT,NN,CC,VBZ,IN,CD,NN,NN,CD,JJ,NNS,VBG,CD,NN,CC,CD,NN,IN,JJS,NN,.}","{2,0,2,6,6,2,6,0,13,13,13,13,2,27,13,0,18,15,0,22,22,15,0,25,22,0,15,0,31,31,27,34,34,27,34,37,35,0,40,2,0,43,40,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_54,"The uninvolved pleural surface is smooth , glistening and tan ? red .","{The,uninvolved,pleural,surface,is,smooth,,,glistening,and,tan,?,red,.}","{the,uninvolved,pleural,surface,be,smooth,,,glistening,and,tan,?,red,.}","{DT,JJ,JJ,NN,VBZ,JJ,,,JJ,CC,NN,CD,NN,.}","{4,4,4,12,12,12,0,6,0,12,12,0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_55,"The uninvolved pulmonary parenchyma is homogeneous , tan ? pink and aerated .","{The,uninvolved,pulmonary,parenchyma,is,homogeneous,,,tan,?,pink,and,aerated,.}","{the,uninvolved,pulmonary,parenchyma,be,homogeneous,,,tan,?,pink,and,aerated,.}","{DT,JJ,JJ,NN,VBZ,JJ,,,NN,CD,NN,CC,JJ,.}","{4,4,4,12,6,0,0,10,10,6,0,6,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_56,"Representative sections of the specimen are submitted .","{Representative,sections,of,the,specimen,are,submitted,.}","{Representative,section,of,the,specimen,be,submit,.}","{NNP,NNS,IN,DT,NN,VBP,VBN,.}","{2,7,0,5,2,7,0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_57,"4 .","{4,.}","{4,.}","{LS,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_58,"Part four is received in saline , labeled ? level 11 lymph node near right upper lobe ? .","{Part,four,is,received,in,saline,,,labeled,?,level,11,lymph,node,near,right,upper,lobe,?,.}","{Part,four,be,receive,in,saline,,,label,?,level,11,lymph,node,near,right,upper,lobe,?,.}","{NNP,CD,VBZ,VBN,IN,NN,,,VBN,JJ,NN,CD,NN,NN,IN,JJ,JJ,NN,NN,.}","{4,1,4,0,0,4,0,6,13,13,13,13,8,0,18,18,18,8,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_59,"It consists of a 2.4 X 1.2 X 0.3 cm irregular portion of black soft rubbery anthracotic lymph node .","{It,consists,of,a,2.4,X,1.2,X,0.3,cm,irregular,portion,of,black,soft,rubbery,anthracotic,lymph,node,.}","{it,consist,of,a,2.4,x,1.2,x,0.3,cm,irregular,portion,of,black,soft,rubbery,anthracotic,lymph,node,.}","{PRP,VBZ,IN,DT,CD,NN,CD,NN,CD,NN,JJ,NN,IN,JJ,JJ,JJ,JJ,NN,NN,.}","{2,0,0,6,6,2,8,12,10,11,12,2,0,19,19,19,19,19,12,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_60,"Entirely submitted in one cassette .","{Entirely,submitted,in,one,cassette,.}","{entirely,submit,in,one,cassette,.}","{RB,VBN,IN,CD,NN,.}","{2,0,0,5,2,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_61,"5 .","{5,.}","{5,.}","{CD,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_62,"Part five is received in saline , labeled ? level 7 lymph node ? .","{Part,five,is,received,in,saline,,,labeled,?,level,7,lymph,node,?,.}","{Part,five,be,receive,in,saline,,,label,?,level,7,lymph,node,?,.}","{NNP,CD,VBZ,VBN,IN,NN,,,VBN,JJ,NN,CD,NN,NN,NN,.}","{4,1,4,0,0,4,0,6,14,14,14,14,14,8,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_63,"It consists of a 3.8 X 3.5 X 1 cm aggregate of black soft rubbery anthracotic lymphoid tissue .","{It,consists,of,a,3.8,X,3.5,X,1,cm,aggregate,of,black,soft,rubbery,anthracotic,lymphoid,tissue,.}","{it,consist,of,a,3.8,x,3.5,x,1,cm,aggregate,of,black,soft,rubbery,anthracotic,lymphoid,tissue,.}","{PRP,VBZ,IN,DT,CD,NN,CD,NN,CD,NN,NN,IN,JJ,JJ,JJ,JJ,JJ,NN,.}","{2,0,0,6,6,2,6,11,11,11,2,0,18,18,18,18,18,11,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_64,"Entirely submitted in three cassettes .","{Entirely,submitted,in,three,cassettes,.}","{entirely,submit,in,three,cassette,.}","{RB,VBN,IN,CD,NNS,.}","{2,0,0,5,2,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_65,"6 .","{6,.}","{6,.}","{CD,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_66,"Part siX is received in saline , labeled ? right level 4 lymph node ? .","{Part,siX,is,received,in,saline,,,labeled,?,right,level,4,lymph,node,?,.}","{Part,siX,be,receive,in,saline,,,label,?,right,level,4,lymph,node,?,.}","{NNP,NNP,VBZ,VBN,IN,NN,,,VBN,RB,JJ,NN,CD,NN,NN,NN,.}","{2,4,4,0,0,4,0,6,10,11,8,15,15,15,11,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_67,"It consists of a 2 X 1.5 X 0.8 cm aggregate of black soft rubbery anthracotic lymphoid tissue admiXed with pink soft tissue .","{It,consists,of,a,2,X,1.5,X,0.8,cm,aggregate,of,black,soft,rubbery,anthracotic,lymphoid,tissue,admiXed,with,pink,soft,tissue,.}","{it,consist,of,a,2,x,1.5,x,0.8,cm,aggregate,of,black,soft,rubbery,anthracotic,lymphoid,tissue,admix,with,pink,soft,tissue,.}","{PRP,VBZ,IN,DT,CD,NN,CD,NN,CD,NN,NN,IN,JJ,JJ,JJ,JJ,JJ,NN,VBN,IN,JJ,JJ,NN,.}","{2,0,0,6,6,2,6,11,11,11,2,0,18,18,18,18,18,11,18,0,23,23,19,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_68,"Entirely submitted in one cassette .","{Entirely,submitted,in,one,cassette,.}","{entirely,submit,in,one,cassette,.}","{RB,VBN,IN,CD,NN,.}","{2,0,0,5,2,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_69,"7 .","{7,.}","{7,.}","{CD,.}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_70,"Part seven is received in fonnalin , labeled ? rib ? .","{Part,seven,is,received,in,fonnalin,,,labeled,?,rib,?,.}","{Part,seven,be,receive,in,fonnalin,,,label,?,rib,?,.}","{NNP,CD,VBZ,VBN,IN,NN,,,VBN,CD,NN,NN,.}","{4,1,4,0,0,4,0,6,11,11,8,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_71,"It consists of a 1.5 cm in length X 1.3 cm in width and 0.7 cm in thickness portion of rib .","{It,consists,of,a,1.5,cm,in,length,X,1.3,cm,in,width,and,0.7,cm,in,thickness,portion,of,rib,.}","{it,consist,of,a,1.5,cm,in,length,x,1.3,cm,in,width,and,0.7,cm,in,thickness,portion,of,rib,.}","{PRP,VBZ,IN,DT,CD,NN,IN,NN,NN,CD,NN,IN,NN,CC,CD,NN,IN,NN,NN,IN,NN,.}","{2,0,0,6,6,2,0,9,6,11,2,0,11,0,16,11,0,19,16,0,19,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_72,"The surface is tan ? brown and smooth .","{The,surface,is,tan,?,brown,and,smooth,.}","{the,surface,be,tan,?,brown,and,smooth,.}","{DT,NN,VBZ,NN,CD,JJ,CC,JJ,.}","{2,4,4,0,4,4,0,4,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_73,"The marrow cavity is red and porous .","{The,marrow,cavity,is,red,and,porous,.}","{the,marrow,cavity,be,red,and,porous,.}","{DT,NN,NN,VBZ,JJ,CC,JJ,.}","{3,3,5,5,0,0,5,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_74,"There are no abnormalities identified .","{There,are,no,abnormalities,identified,.}","{there,be,no,abnormality,identify,.}","{EX,VBP,DT,NNS,VBN,.}","{2,0,4,2,4,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_75,"Representative sections are submitted in one cassette following decalcification .","{Representative,sections,are,submitted,in,one,cassette,following,decalcification,.}","{Representative,section,be,submit,in,one,cassette,follow,decalcification,.}","{NNP,NNS,VBP,VBN,IN,CD,NN,VBG,NN,.}","{2,4,4,0,0,7,4,0,7,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_76,"SUMMARY OF SECTIONS : 2A entirely submitted 3A bronchial margin , en face 3B vascular margin , en face 3C tumor , adjacent bronchus 3D tumor , adjacent vasculature 3E ? 3G tumor , pleura 3H ? 3J tumor , uninvolved parenchyma 3K finn nodules , superior portion of lobe 3L uninvolved parenchyma 3M possible hilar lymph nodes 4A entirely submitted","{SUMMARY,OF,SECTIONS,:,2A,entirely,submitted,3A,bronchial,margin,,,en,face,3B,vascular,margin,,,en,face,3C,tumor,,,adjacent,bronchus,3D,tumor,,,adjacent,vasculature,3E,?,3G,tumor,,,pleura,3H,?,3J,tumor,,,uninvolved,parenchyma,3K,finn,nodules,,,superior,portion,of,lobe,3L,uninvolved,parenchyma,3M,possible,hilar,lymph,nodes,4A,entirely,submitted}","{summary,of,section,:,2a,entirely,submit,3a,bronchial,margin,,,en,face,3b,vascular,margin,,,en,face,3c,tumor,,,adjacent,bronchus,3d,tumor,,,adjacent,vasculature,3e,?,3g,tumor,,,pleuron,3h,?,3j,tumor,,,uninvolved,parenchyma,3k,finn,nodule,,,superior,portion,of,lobe,3l,uninvolved,parenchyma,3M,possible,hilar,lymph,node,4a,entirely,submit}","{NN,IN,NNS,:,NN,RB,VBD,NN,JJ,NN,,,IN,NN,NN,JJ,NN,,,IN,NN,NN,NN,,,JJ,NNS,NN,NN,,,JJ,NN,NN,CD,NN,NN,,,NN,NN,CD,NN,NN,,,JJ,NN,NN,NN,NNS,,,JJ,NN,IN,NN,NN,JJ,NN,NNP,JJ,JJ,NN,NNS,VBP,RB,VBN}","{0,0,1,0,7,7,1,10,10,7,0,0,16,16,16,7,0,7,21,21,45,0,26,26,26,21,0,33,33,33,33,33,21,0,36,21,38,45,45,0,45,45,45,45,54,0,48,45,0,53,53,53,45,1,58,58,58,59,54,59,59}","{}"
TCGA-97-8547, TCGA-97-8547SENT_77,"5A ? 5C entirely submitted 6A entirely submitted 7A representative","{5A,?,5C,entirely,submitted,6A,entirely,submitted,7A,representative}","{5a,?,5c,entirely,submit,6a,entirely,submit,7a,representative}","{NN,CD,NN,RB,VBD,NN,RB,VBD,NN,NN}","{5,3,4,1,0,8,8,5,10,8}","{}"
TCGA-97-8547, TCGA-97-8547SENT_78,"SPECIAL PROCEDURES : TTF1 , PAX ? 8 , ERG .","{SPECIAL,PROCEDURES,:,TTF1,,,PAX,?,8,,,ERG,.}","{special,procedure,:,ttf1,,,PAX,?,8,,,ERG,.}","{JJ,NNS,:,NN,,,NNP,CD,CD,,,NNP,.}","{2,0,0,2,0,2,8,6,0,2,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_79,"AFB , GMS , ELASTIC","{AFB,,,GMS,,,ELASTIC}","{AFB,,,GMS,,,ELASTIC}","{NNP,,,NNP,,,NNP}","{0,0,5,0,1}","{}"
TCGA-97-8547, TCGA-97-8547SENT_80,"ADDENDUM # 1 :","{ADDENDUM,#,1,:}","{ADDENDUM,#,1,:}","{NNP,#,CD,:}","{0,3,1,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_81,"INTEGRATED ONCOLOGY","{INTEGRATED,ONCOLOGY}","{integrate,oncology}","{VBN,NN}","{0,1}","{}"
TCGA-97-8547, TCGA-97-8547SENT_82,"MOLECULAR ONCOLOGY KRAS MUTATION ANALYSIS","{MOLECULAR,ONCOLOGY,KRAS,MUTATION,ANALYSIS}","{molecular,ONCOLOGY,KRAS,MUTATION,ANALYSIS}","{JJ,NNP,NNP,NNP,NNP}","{5,5,5,5,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_83,"Body Site : Lung Specimen Type : Slides Clinical Data : Adenocarcinoma","{Body,Site,:,Lung,Specimen,Type,:,Slides,Clinical,Data,:,Adenocarcinoma}","{body,site,:,lung,specimen,type,:,slide,clinical,datum,:,adenocarcinoma}","{NN,NN,:,NN,NN,NN,:,NNS,JJ,NNS,:,NN}","{0,1,0,6,6,1,0,6,10,8,0,6}","{}"
TCGA-97-8547, TCGA-97-8547SENT_84,"RESULTS : Wild ? type gene .","{RESULTS,:,Wild,?,type,gene,.}","{result,:,Wild,?,type,gene,.}","{NNS,:,NNP,CD,NN,NN,.}","{0,0,1,6,6,3,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_85,"INTERPRETATION : No mutations were identified at codons l2 and 13 of the KRAS gene .","{INTERPRETATION,:,No,mutations,were,identified,at,codons,l2,and,13,of,the,KRAS,gene,.}","{interpretation,:,no,mutation,be,identify,at,codon,l2,and,13,of,the,KRAS,gene,.}","{NN,:,DT,NNS,VBD,VBN,IN,NNS,NN,CC,CD,IN,DT,NNP,NN,.}","{0,0,4,6,6,1,0,9,6,0,6,0,15,15,11,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_86,"COMMENT : Mutations in the KRAS gene are reported to be associated with poor prognosis , and resistance to targeted tyrosine kinase inhibitor therapies in patients with non ? small ? cell lung cancer ( NSCLC ) .","{COMMENT,:,Mutations,in,the,KRAS,gene,are,reported,to,be,associated,with,poor,prognosis,,,and,resistance,to,targeted,tyrosine,kinase,inhibitor,therapies,in,patients,with,non,?,small,?,cell,lung,cancer,(,NSCLC,),.}","{COMMENT,:,mutation,in,the,KRAS,gene,be,report,to,be,associate,with,poor,prognosis,,,and,resistance,to,target,tyrosine,kinase,inhibitor,therapy,in,patient,with,non,?,small,?,cell,lung,cancer,(,nsclc,),.}","{NNP,:,NNS,IN,DT,NNP,NN,VBP,VBN,TO,VB,VBN,IN,JJ,NN,,,CC,NN,TO,VBN,NN,NN,NN,NNS,IN,NNS,IN,JJ,JJ,JJ,NN,NN,NN,NN,CD,NN,NN,.}","{0,0,9,0,7,7,3,9,1,12,12,9,0,15,12,0,0,15,0,37,24,24,24,20,0,24,0,36,36,36,36,36,36,36,36,26,12,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_87,"KRAS mutations occur in 15-30 % of non ? small ? cell lung cancer ( NSCLC ) patients and are strongly associated with adenocarcinoma and smoking history .","{KRAS,mutations,occur,in,15-30,%,of,non,?,small,?,cell,lung,cancer,(,NSCLC,),patients,and,are,strongly,associated,with,adenocarcinoma,and,smoking,history,.}","{KRAS,mutation,occur,in,15-30,%,of,non,?,small,?,cell,lung,cancer,(,nsclc,),patient,and,be,strongly,associate,with,adenocarcinoma,and,smoking,history,.}","{NNP,NNS,VBP,IN,CD,NN,IN,JJ,JJ,JJ,NN,NN,NN,NN,CD,NN,CD,NNS,CC,VBP,RB,VBN,IN,NN,CC,NN,NN,.}","{2,3,0,0,6,3,0,16,16,16,16,16,16,16,16,6,18,3,0,22,22,3,0,27,0,27,22,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_88,"This assay analyzes codons l2 and 13 in exon 2 of the KRAS gene ; based on the current literature , approximately 98 % of mutations are expected to occur in these codons .","{This,assay,analyzes,codons,l2,and,13,in,exon,2,of,the,KRAS,gene,;,based,on,the,current,literature,,,approximately,98,%,of,mutations,are,expected,to,occur,in,these,codons,.}","{this,assay,analyze,codon,l2,and,13,in,exon,2,of,the,KRAS,gene,;,base,on,the,current,literature,,,approximately,98,%,of,mutation,be,expect,to,occur,in,these,codon,.}","{DT,NN,VBZ,NNS,NN,CC,CD,IN,NN,CD,IN,DT,NNP,NN,:,VBN,IN,DT,JJ,NN,,,RB,CD,NN,IN,NNS,VBP,VBN,TO,VB,IN,DT,NNS,.}","{2,3,0,5,3,0,5,0,3,9,0,14,14,9,0,0,28,20,20,28,0,23,24,28,0,24,28,3,30,28,0,33,30,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_89,"The analytical sensitivity of the assay is approximately 10 % ; thus mutations present in a low percentage of cells may not be detected .","{The,analytical,sensitivity,of,the,assay,is,approximately,10,%,;,thus,mutations,present,in,a,low,percentage,of,cells,may,not,be,detected,.}","{the,analytical,sensitivity,of,the,assay,be,approximately,10,%,;,thus,mutation,present,in,a,low,percentage,of,cell,may,not,be,detect,.}","{DT,JJ,NN,IN,DT,NN,VBZ,RB,CD,NN,:,RB,NNS,JJ,IN,DT,JJ,NN,IN,NNS,MD,RB,VB,VBN,.}","{3,3,10,0,6,3,10,9,10,0,0,24,24,13,0,18,18,14,0,18,24,24,24,10,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_90,"This test is Validated for use in identifying KRAS codon 12 and codon 13 mutations in fresh , frozen , or fonnalin ? fixed paraffin embedded tissue .","{This,test,is,Validated,for,use,in,identifying,KRAS,codon,12,and,codon,13,mutations,in,fresh,,,frozen,,,or,fonnalin,?,fixed,paraffin,embedded,tissue,.}","{this,test,be,validate,for,use,in,identify,KRAS,codon,12,and,codon,13,mutation,in,fresh,,,frozen,,,or,fonnalin,?,fix,paraffin,embedded,tissue,.}","{DT,NN,VBZ,VBN,IN,NN,IN,VBG,NNP,NN,CD,CC,NN,CD,NNS,IN,JJ,,,JJ,,,CC,NN,NN,VBN,NN,JJ,NN,.}","{2,4,4,0,0,4,0,4,10,15,10,0,10,15,8,0,19,0,15,0,0,23,15,15,27,27,24,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_91,"In particular the test performance has been established in samples of colorectal cancer and non ? small cell lung carcinoma which harbor these mutations , although several other tissues are also known to harbor KRAS mutations ( e.g. tumors of pancreas , bile duct , ovary , appendix , etc. ) .","{In,particular,the,test,performance,has,been,established,in,samples,of,colorectal,cancer,and,non,?,small,cell,lung,carcinoma,which,harbor,these,mutations,,,although,several,other,tissues,are,also,known,to,harbor,KRAS,mutations,(,e.g.,tumors,of,pancreas,,,bile,duct,,,ovary,,,appendix,,,etc.,),.}","{in,particular,the,test,performance,have,be,establish,in,sample,of,colorectal,cancer,and,non,?,small,cell,lung,carcinoma,which,harbor,these,mutation,,,although,several,other,tissue,be,also,know,to,harbor,KRAS,mutation,(,e.g.,tumor,of,pancreas,,,bile,duct,,,ovary,,,appendix,,,etc.,),.}","{IN,JJ,DT,NN,NN,VBZ,VBN,VBN,IN,NNS,IN,JJ,NN,CC,JJ,JJ,JJ,NN,NN,NN,WDT,VBP,DT,NNS,,,IN,JJ,JJ,NNS,VBP,RB,VBN,TO,VB,NNP,NNS,CD,FW,NNS,IN,NN,,,NN,NN,,,NN,,,NN,,,FW,FW,.}","{0,8,5,5,8,8,8,0,0,8,0,13,10,0,20,20,20,20,20,10,22,20,24,22,0,32,29,29,32,32,32,8,34,32,36,39,39,39,34,0,39,0,44,41,0,41,0,41,0,51,41,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_92,"Analysis of EGFR mutation or gene amplification status may provide additional infonnation regarding this patient 's probability of response to targeted tyrosine kinase inhibitor therapies , if clinically indicated .","{Analysis,of,EGFR,mutation,or,gene,amplification,status,may,provide,additional,infonnation,regarding,this,patient,'s,probability,of,response,to,targeted,tyrosine,kinase,inhibitor,therapies,,,if,clinically,indicated,.}","{analysis,of,egfr,mutation,or,gene,amplification,status,may,provide,additional,infonnation,regard,this,patient,'s,probability,of,response,to,target,tyrosine,kinase,inhibitor,therapy,,,if,clinically,indicate,.}","{NN,IN,NN,NN,CC,NN,NN,NN,MD,VB,JJ,NN,VBG,DT,NN,POS,NN,IN,NN,TO,VBN,NN,NN,NN,NNS,,,IN,RB,VBN,.}","{10,0,4,1,0,8,8,4,10,0,12,10,0,15,17,0,12,0,17,0,10,25,25,25,21,0,29,29,21,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_93,"See references .","{See,references,.}","{see,reference,.}","{VB,NNS,.}","{0,1,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_94,"METHOD/LIMITATIONS : Tissue sections are reviewed by a pathologist and relevant tumor is selected for analysis .","{METHOD/LIMITATIONS,:,Tissue,sections,are,reviewed,by,a,pathologist,and,relevant,tumor,is,selected,for,analysis,.}","{METHOD/LIMITATIONS,:,tissue,section,be,review,by,a,pathologist,and,relevant,tumor,be,select,for,analysis,.}","{NNP,:,NN,NNS,VBP,VBN,IN,DT,NN,CC,JJ,NN,VBZ,VBN,IN,NN,.}","{0,0,4,6,6,1,0,9,6,0,12,14,14,6,0,14,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_95,"DNA is isolated from the sample , quantified and amplified by polymerase chain reaction ( PCR ) using primers to exon 2 of the KRAS gene .","{DNA,is,isolated,from,the,sample,,,quantified,and,amplified,by,polymerase,chain,reaction,(,PCR,),using,primers,to,exon,2,of,the,KRAS,gene,.}","{dna,be,isolate,from,the,sample,,,quantify,and,amplify,by,polymerase,chain,reaction,(,pcr,),use,primer,to,exon,2,of,the,KRAS,gene,.}","{NN,VBZ,VBN,IN,DT,NN,,,VBN,CC,VBN,IN,NN,NN,NN,CD,NN,NN,VBG,NNS,TO,NN,CD,IN,DT,NNP,NN,.}","{10,3,0,0,6,3,0,3,0,3,0,17,17,17,17,17,10,17,18,0,18,21,0,26,26,21,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_96,"PCR products are subjected to single nucleotide primer extension to detect mutations at codons l2 and 13 ; primer extension products are analyzed using capillary gel electrophoresis and ?uorescence detection .","{PCR,products,are,subjected,to,single,nucleotide,primer,extension,to,detect,mutations,at,codons,l2,and,13,;,primer,extension,products,are,analyzed,using,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{pcr,product,be,subject,to,single,nucleotide,primer,extension,to,detect,mutation,at,codon,l2,and,13,;,primer,extension,product,be,analyze,use,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{NN,NNS,VBP,VBN,TO,JJ,NN,NN,NN,TO,VB,NNS,IN,NNS,NN,CC,CD,:,NN,NN,NNS,VBP,VBN,VBG,JJ,NN,NN,CC,NN,NN,.}","{2,4,4,0,0,9,9,9,4,11,4,11,0,15,11,0,11,0,21,21,23,23,4,23,27,27,24,0,30,27,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_97,"False positive or negative results may occur for reasons that include genetic variants or somatic heterogeneity of the tissue sample .","{False,positive,or,negative,results,may,occur,for,reasons,that,include,genetic,variants,or,somatic,heterogeneity,of,the,tissue,sample,.}","{false,positive,or,negative,result,may,occur,for,reason,that,include,genetic,variant,or,somatic,heterogeneity,of,the,tissue,sample,.}","{JJ,JJ,CC,JJ,NNS,MD,VB,IN,NNS,WDT,VBP,JJ,NNS,CC,JJ,NN,IN,DT,NN,NN,.}","{5,5,0,2,7,7,0,0,7,11,9,13,11,0,16,13,0,20,20,16,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_98,"REFERENCES :","{REFERENCES,:}","{reference,:}","{NNS,:}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_99,"Addendum # 1 ierformed by ADDENDUM # 2 :","{Addendum,#,1,ierformed,by,ADDENDUM,#,2,:}","{Addendum,#,1,ierform,by,ADDENDUM,#,2,:}","{NNP,#,CD,VBN,IN,NNP,#,CD,:}","{0,3,1,1,0,4,8,6,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_100,"INTEGRATED ONCOLOGY","{INTEGRATED,ONCOLOGY}","{integrate,oncology}","{VBN,NN}","{0,1}","{}"
TCGA-97-8547, TCGA-97-8547SENT_101,"EGFR Mutation Anal sis","{EGFR,Mutation,Anal,sis}","{egfr,mutation,anal,si}","{NN,NN,JJ,NN}","{2,0,4,2}","{}"
TCGA-97-8547, TCGA-97-8547SENT_102,"Body Site : Lung Clinical Data : Adenocarcinoma","{Body,Site,:,Lung,Clinical,Data,:,Adenocarcinoma}","{body,site,:,lung,clinical,datum,:,adenocarcinoma}","{NN,NN,:,NN,JJ,NNS,:,NN}","{0,1,0,6,6,1,0,6}","{}"
TCGA-97-8547, TCGA-97-8547SENT_103,"RESULTS : Positive for the E746_A750del5 mutation in Exon 19 .","{RESULTS,:,Positive,for,the,E746_A750del5,mutation,in,Exon,19,.}","{result,:,positive,for,the,e746_a750del5,mutation,in,Exon,19,.}","{NNS,:,JJ,IN,DT,NN,NN,IN,NNP,CD,.}","{0,0,1,0,7,7,3,0,7,9,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_104,"INTERPRETATION : Deletion mutations in exon 19 , mostly involving the LREA motif , are reported to correlate with responsiveness to EGFR tyrosine kinase inhibitor therapies in patients with non ? small ? cell lung carcinoma .","{INTERPRETATION,:,Deletion,mutations,in,exon,19,,,mostly,involving,the,LREA,motif,,,are,reported,to,correlate,with,responsiveness,to,EGFR,tyrosine,kinase,inhibitor,therapies,in,patients,with,non,?,small,?,cell,lung,carcinoma,.}","{interpretation,:,deletion,mutation,in,exon,19,,,mostly,involve,the,lrea,motif,,,be,report,to,correlate,with,responsiveness,to,egfr,tyrosine,kinase,inhibitor,therapy,in,patient,with,non,?,small,?,cell,lung,carcinoma,.}","{NN,:,NN,NNS,IN,NN,CD,,,RB,VBG,DT,NN,NN,,,VBP,VBN,TO,VB,IN,NN,TO,NN,NN,NN,NN,NNS,IN,NNS,IN,JJ,JJ,JJ,NN,NN,NN,NN,.}","{16,0,4,1,10,5,6,0,10,4,13,13,10,0,16,0,18,16,0,18,0,26,26,26,26,18,0,18,0,36,36,36,36,36,36,28,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_105,"COMMENT : Forty percent ( 40 % ) or more tumor cellularity is optimal for this mutation analysis .","{COMMENT,:,Forty,percent,(,40,%,),or,more,tumor,cellularity,is,optimal,for,this,mutation,analysis,.}","{COMMENT,:,forty,percent,(,40,%,),or,more,tumor,cellularity,be,optimal,for,this,mutation,analysis,.}","{NNP,:,CD,NN,CD,CD,NN,CD,CC,JJR,NN,NN,VBZ,JJ,IN,DT,NN,NN,.}","{0,0,4,14,7,7,4,4,0,4,12,8,14,1,0,18,18,14,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_106,"The sample submitted showed 30 % tumor cellularity upon pathologist review .","{The,sample,submitted,showed,30,%,tumor,cellularity,upon,pathologist,review,.}","{the,sample,submit,show,30,%,tumor,cellularity,upon,pathologist,review,.}","{DT,NN,VBN,VBD,CD,NN,NN,NN,IN,NN,NN,.}","{2,4,2,0,6,8,8,4,0,11,4,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_107,"E746_A750del l 5 corresponds to 2235_2249del l 5 .","{E746_A750del,l,5,corresponds,to,2235_2249del,l,5,.}","{e746_a750del,l,5,correspond,to,2235_2249del,l,5,.}","{NN,NN,CD,VBZ,TO,JJ,NN,CD,.}","{2,4,4,0,0,7,4,7,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_108,"A frequently occurring sequence change 236lG > A ( Q787Q ) was identified .","{A,frequently,occurring,sequence,change,236lG,>,A,(,Q787Q,),was,identified,.}","{a,frequently,occur,sequence,change,236lg,>,a,(,q787q,),be,identify,.}","{DT,RB,VBG,NN,NN,NN,JJR,DT,CD,NN,NN,VBD,VBN,.}","{6,3,6,6,6,0,6,11,11,11,13,13,7,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_109,"This polymorphism is known not to have clinical significance .","{This,polymorphism,is,known,not,to,have,clinical,significance,.}","{this,polymorphism,be,know,not,to,have,clinical,significance,.}","{DT,NN,VBZ,VBN,RB,TO,VB,JJ,NN,.}","{2,4,4,0,7,7,4,9,7,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_110,"Mutations in the tyrosine domain of the epidennal growth factor receptor ( EGFR ) gene are reported to be associated with differential responsiveness or resistance to EGFR tyrosine kinase inhibitor ( TKI ) therapies .","{Mutations,in,the,tyrosine,domain,of,the,epidennal,growth,factor,receptor,(,EGFR,),gene,are,reported,to,be,associated,with,differential,responsiveness,or,resistance,to,EGFR,tyrosine,kinase,inhibitor,(,TKI,),therapies,.}","{mutation,in,the,tyrosine,domain,of,the,epidennal,growth,factor,receptor,(,egfr,),gene,be,report,to,be,associate,with,differential,responsiveness,or,resistance,to,egfr,tyrosine,kinase,inhibitor,(,tkus,),therapy,.}","{NNS,IN,DT,NN,NN,IN,DT,JJ,NN,NN,NN,CD,NN,NN,NN,VBP,VBN,TO,VB,VBN,IN,JJ,NN,CC,NN,TO,NN,NN,NN,NN,NN,NN,CD,NNS,.}","{17,0,5,5,1,0,11,11,11,11,5,15,15,15,11,17,0,20,20,17,0,23,20,0,23,0,32,32,32,32,32,20,34,32,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_111,"The objective response rate among patients with a sensitizing mutation ranges from 55 to 82 % .","{The,objective,response,rate,among,patients,with,a,sensitizing,mutation,ranges,from,55,to,82,%,.}","{the,objective,response,rate,among,patient,with,a,sensitize,mutation,range,from,55,to,82,%,.}","{DT,JJ,NN,NN,IN,NNS,IN,DT,VBG,NN,NNS,IN,CD,TO,CD,NN,.}","{4,4,4,0,0,4,0,11,11,11,6,0,15,15,16,11,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_112,"This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain ; based on the current literature , most mutations in non ? small ? cell lung carcinoma ( NSCLC ) are expected to occur in these exons .","{This,assay,analyzes,exons,18-21,of,the,EGFR,tyrosine,kinase,domain,;,based,on,the,current,literature,,,most,mutations,in,non,?,small,?,cell,lung,carcinoma,(,NSCLC,),are,expected,to,occur,in,these,exons,.}","{this,assay,analyze,exon,18-21,of,the,egfr,tyrosine,kinase,domain,;,base,on,the,current,literature,,,most,mutation,in,non,?,small,?,cell,lung,carcinoma,(,nsclc,),be,expect,to,occur,in,these,exon,.}","{DT,NN,VBZ,NNS,CD,IN,DT,NN,NN,NN,NN,:,VBN,IN,DT,JJ,NN,,,JJS,NNS,IN,JJ,JJ,JJ,NN,NN,NN,NN,CD,NN,NN,VBP,VBN,TO,VB,IN,DT,NNS,.}","{2,3,0,3,4,0,11,11,11,11,4,0,0,33,17,17,33,0,20,17,0,28,28,28,28,28,28,20,31,31,33,33,3,35,33,0,38,35,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_113,"Mutations present in less than 10-20 % of extracted DNA may not be detected by this method .","{Mutations,present,in,less,than,10-20,%,of,extracted,DNA,may,not,be,detected,by,this,method,.}","{mutation,present,in,less,than,10-20,%,of,extract,dna,may,not,be,detect,by,this,method,.}","{NNS,JJ,IN,JJR,IN,CD,NN,IN,VBN,NN,MD,RB,VB,VBN,IN,DT,NN,.}","{14,1,0,5,6,7,2,0,10,7,14,14,14,0,0,17,14,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_114,"Mutation status in a sample may change during tumor progression or the course of therapy ; therefore , this result can not be used to infer the presence or absence of a mutation in another sample or sub ? sample obtained from this tumor .","{Mutation,status,in,a,sample,may,change,during,tumor,progression,or,the,course,of,therapy,;,therefore,,,this,result,can,not,be,used,to,infer,the,presence,or,absence,of,a,mutation,in,another,sample,or,sub,?,sample,obtained,from,this,tumor,.}","{mutation,status,in,a,sample,may,change,during,tumor,progression,or,the,course,of,therapy,;,therefore,,,this,result,can,not,be,use,to,infer,the,presence,or,absence,of,a,mutation,in,another,sample,or,sub,?,sample,obtain,from,this,tumor,.}","{NN,NN,IN,DT,NN,MD,VB,IN,NN,NN,CC,DT,NN,IN,NN,:,RB,,,DT,NN,MD,RB,VB,VBN,TO,VB,DT,NN,CC,NN,IN,DT,NN,IN,DT,NN,CC,NN,CD,NN,VBN,IN,DT,NN,.}","{2,7,0,5,2,7,0,0,10,7,0,13,10,0,13,0,24,0,20,24,24,24,24,7,26,24,28,26,0,28,0,33,28,0,36,33,0,40,40,33,40,0,44,41,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_115,"This test is validated for non ? small cell lung carcinoma .","{This,test,is,validated,for,non,?,small,cell,lung,carcinoma,.}","{this,test,be,validate,for,non,?,small,cell,lung,carcinoma,.}","{DT,NN,VBZ,VBN,IN,JJ,JJ,JJ,NN,NN,NN,.}","{2,4,4,0,0,11,11,11,11,11,4,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_116,"The clinical significance and utility of this test in other tumor types is unknown .","{The,clinical,significance,and,utility,of,this,test,in,other,tumor,types,is,unknown,.}","{the,clinical,significance,and,utility,of,this,test,in,other,tumor,type,be,unknown,.}","{DT,JJ,NN,CC,NN,IN,DT,NN,IN,JJ,NN,NNS,VBZ,JJ,.}","{3,3,14,0,14,0,8,3,0,12,12,8,14,0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_117,"METHOD/LIMITATION : Tissue sections are reviewed by a pathologist and relevant tumor is selected for analysis .","{METHOD/LIMITATION,:,Tissue,sections,are,reviewed,by,a,pathologist,and,relevant,tumor,is,selected,for,analysis,.}","{METHOD/LIMITATION,:,tissue,section,be,review,by,a,pathologist,and,relevant,tumor,be,select,for,analysis,.}","{NNP,:,NN,NNS,VBP,VBN,IN,DT,NN,CC,JJ,NN,VBZ,VBN,IN,NN,.}","{0,0,4,6,6,1,0,9,6,0,12,14,14,6,0,14,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_118,"DNA is isolated from the samples , quantified and amplified by polymerase chain reaction ( PCR ) using primers to exons 18-21 of the EGFR gene .","{DNA,is,isolated,from,the,samples,,,quantified,and,amplified,by,polymerase,chain,reaction,(,PCR,),using,primers,to,exons,18-21,of,the,EGFR,gene,.}","{dna,be,isolate,from,the,sample,,,quantify,and,amplify,by,polymerase,chain,reaction,(,pcr,),use,primer,to,exon,18-21,of,the,egfr,gene,.}","{NN,VBZ,VBN,IN,DT,NNS,,,VBN,CC,VBN,IN,NN,NN,NN,CD,NN,NN,VBG,NNS,TO,NNS,CD,IN,DT,NN,NN,.}","{10,3,0,0,6,3,0,3,0,3,0,17,17,17,17,17,10,17,18,0,18,21,0,26,26,21,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_119,"PCR products are analyzed by bi ? directional direct DNA sequencing using capillary gel electrophoresis and ?uorescence detection .","{PCR,products,are,analyzed,by,bi,?,directional,direct,DNA,sequencing,using,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{pcr,product,be,analyze,by,bus,?,directional,direct,dna,sequencing,use,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{NN,NNS,VBP,VBN,IN,NN,CD,JJ,JJ,NN,NN,VBG,JJ,NN,NN,CC,NN,NN,.}","{2,4,4,0,0,4,11,11,11,11,4,11,15,15,12,0,18,12,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_120,"False positive or negative results may occur for reasons that include genetic variants or somatic heterogeneity of the tissue sample .","{False,positive,or,negative,results,may,occur,for,reasons,that,include,genetic,variants,or,somatic,heterogeneity,of,the,tissue,sample,.}","{false,positive,or,negative,result,may,occur,for,reason,that,include,genetic,variant,or,somatic,heterogeneity,of,the,tissue,sample,.}","{JJ,JJ,CC,JJ,NNS,MD,VB,IN,NNS,WDT,VBP,JJ,NNS,CC,JJ,NN,IN,DT,NN,NN,.}","{5,5,0,2,7,7,0,0,7,11,9,13,11,0,16,13,0,20,20,16,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_121,"REFERENCES :","{REFERENCES,:}","{reference,:}","{NNS,:}","{0,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_122,"Addendum # 2 erformed by","{Addendum,#,2,erformed,by}","{Addendum,#,2,erform,by}","{NNP,#,CD,VBN,IN}","{0,3,1,1,4}","{}"
TCGA-97-8547, TCGA-97-8547SENT_123,"They have not been cleared or approved by the US Food and Drug Administration .","{They,have,not,been,cleared,or,approved,by,the,US,Food,and,Drug,Administration,.}","{they,have,not,be,clear,or,approve,by,the,US,Food,and,Drug,Administration,.}","{PRP,VBP,RB,VBN,VBN,CC,VBN,IN,DT,NNP,NNP,CC,NNP,NNP,.}","{7,5,5,5,0,0,5,0,11,11,5,0,14,5,0}","{}"
TCGA-97-8547, TCGA-97-8547SENT_124,"The FDA has detennined that such clearance or approval is not necessary .","{The,FDA,has,detennined,that,such,clearance,or,approval,is,not,necessary,.}","{the,FDA,have,detennine,that,such,clearance,or,approval,be,not,necessary,.}","{DT,NNP,VBZ,VBN,IN,JJ,NN,CC,NN,VBZ,RB,JJ,.}","{2,4,4,0,12,7,12,0,12,12,12,4,0}","{}"
